ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Robert J. Keenan
Akihiko Kawai
Robert L. Hardesty
Bartley P. Griffith
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keenan, R. J.
Right arrow Articles by Griffith, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keenan, R. J.
Right arrow Articles by Griffith, B. P.
Related Collections
Right arrowRelated Articles

Ann Thorac Surg 1995;60:580-584
© 1995 The Society of Thoracic Surgeons

Original Articles: General Thoracic

Clinical Trial of Tacrolimus Versus Cyclosporine in Lung Transplantation

Robert J. Keenan, MD, Heroaki Konishi, MD, Akihiko Kawai, MD, Irvin L. Paradis, MD, David R. Nunley, MD, Aldo T. Iacono, MD, Robert L. Hardesty, MD, Robert J. Weyant, DMD, DrPH, Bartley P. Griffith, MD

Divisions of Cardiothoracic Surgery and Pulmonary and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

Background. A prospective clinical trial was undertaken to compare the efficacy of tacrolimus (FK 506) versus cyclosporine as the primary immunosuppressive agent after lung transplantation.

Methods. Between October 1991 and May 1994, 133 single-lung and bilateral-lung recipients were randomized to receive either cyclosporine (n = 67) or tacrolimus (n = 66). The two groups were similar in age, sex, and underlying disease.

Results. One-year and 2-year survival rates were similar in the two groups, although the trend was toward increased survival with tacrolimus. Acute rejection episodes per 100 patient-days were fewer (p = 0.07) in the tacrolimus group (0.85) than in the cyclosporine group (1.09). Obliterative bronchiolitis developed in significantly fewer patients in the tacrolimus group (21.7%) compared with the cyclosporine group (38%) (p= 0.025), and there was greater freedom from obliterative bronchiolitis over time for patients receiving tacrolimus (p < 0.03). Significantly more cyclosporine-treated patients (n = 13) required crossover to tacrolimus than tacrolimus-treated patients to cyclosporine (n = 2) (p = 0.02). The switch to tacrolimus controlled persistent acute rejection in 6 of 9 patients. The overall incidence of infections was similar in the two groups, although bacterial infections were more common with cyclosporine (p = 0.0375), whereas the risk of fungal infection was higher with tacrolimus (p < 0.05).

Conclusions. This trial demonstrates the advantage of tacrolimus in reducing the risk of obliterative bronchiolitis, the most important cause of long-term morbidity and mortality after lung transplantation.


Related Articles

Advantage-FK 506: Reduced Chronic Rejection for Lung Transplant Recipients
R. Morton Bolman, III
Ann. Thorac. Surg. 1995 60: 495-496. [Extract] [Full Text]

Discussion
Ann. Thorac. Surg. 1995 60: 584-585. [Extract] [Full Text]



This article has been cited by other articles:


Home page
 Card Surg AdultHome page
A. Y. Sheikh, M. P. Pelletier, and R. C. Robbins
Heart-Lung and Lung Transplantation
Card. Surg. Adult, January 1, 2008; 3(2008): 1579 - 1608.
[Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
N. Ide, T. Nagayasu, K. Matsumoto, T. Tagawa, K. Tanaka, T. Taguchi, Y. Sumida, and M. Nakashima
Efficacy and safety of inhaled tacrolimus in rat lung transplantation
J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 548 - 553.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
I. Al-Githmi, N. Batawil, N. Shigemura, M. Hsin, T. W. lee, G.-W. He, and A. Yim
Bronchiolitis obliterans following lung transplantation
Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 846 - 851.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
J. L. Taylor and S. M. Palmer
Critical Care Perspective on Immunotherapy in Lung Transplantation
J Intensive Care Med, December 1, 2006; 21(6): 327 - 344.
[Abstract] [PDF]

Home page
 Proc Am Thorac SocHome page
L. P. Nicod
Mechanisms of airway obliteration after lung transplantation.
Proceedings of the ATS, July 1, 2006; 3(5): 444 - 449.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
G. Warnecke, M. Avsar, T. Steinkamp, R. Reinhard, J. Niedermeyer, A. R. Simon, A. Haverich, and M. Struber
Tacrolimus versus cyclosporine induction therapy in pulmonary transplantation in miniature swine
Eur. J. Cardiothorac. Surg., September 1, 2005; 28(3): 454 - 460.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. Sarahrudi, M. Estenne, P. Corris, J. Niedermayer, C. Knoop, A. Glanville, C. Chaparro, G. Verleden, M. W. Gerbase, F. Venuta, et al.
International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection
J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1126 - 1132.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
C. Knoop, A. Haverich, and S. Fischer
Immunosuppressive therapy after human lung transplantation
Eur. Respir. J., January 1, 2004; 23(1): 159 - 171.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
K J Ahn, J W Lee, S T Hahn, D W Yang, P S Kim, H J Kim, and C C Kim
Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity
Br. J. Radiol., December 1, 2003; 76(912): 916 - 919.
[Abstract] [Full Text] [PDF]

Home page
 Am J Crit CareHome page
A. DeVito Dabbs, L. A. Hoffman, A. T. Iacono, C. L. Wells, W. Grgurich, T. G. Zullo, K. R. McCurry, and J. H. Dauber
Pattern and Predictors of Early Rejection After Lung Transplantation
Am. J. Crit. Care., November 1, 2003; 12(6): 497 - 507.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. Zuckermann, H. Reichenspurner, T. Birsan, H. Treede, E. Deviatko, B. Reichart, and W. Klepetko
Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: One-year results of a 2-center prospective randomized trial
J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 891 - 900.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
L. B. Balsam, D. D. Yuh, R. C. Robbins, and B. A. Reitz
Heart-Lung and Lung Transplantation
Card. Surg. Adult, January 1, 2003; 2(2003): 1461 - 1490.
[Full Text]

Home page
 ChestHome page
J. W. K. van den Berg, P. J. van Enckevort, E. M. TenVergert, D. S. Postma, W. van der Bij, and G. H. Koeter
Bronchiolitis Obliterans Syndrome and Additional Costs of Lung Transplantation
Chest, December 1, 2000; 118(6): 1648 - 1652.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J W K van den Berg, D S Postma, G H Koëter, and W van der Bij
New immunosuppressive drugs and lung transplantation: last or least?
Thorax, June 1, 1999; 54(6): 550 - 553.
[Full Text]

Home page
 NEJMHome page
S. M. Arcasoy and R. M. Kotloff
Lung Transplantation
N. Engl. J. Med., April 8, 1999; 340(14): 1081 - 1091.
[Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
D. Metras, L. Viard, B. Kreitmann, A. Riberi, A. Pannetier-Mille, O. Garbi, J.-Y. Marti, and P. Geigle
Lung infections in pediatric lung transplantation: experience in 49 cases
Eur. J. Cardiothorac. Surg., April 1, 1999; 15(4): 490 - 495.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. Longoria, R. F. Roberts, C. C. Marboe, B. C. Stouch, V. A. Starnes, and M. L. Barr
SIROLIMUS (RAPAMYCIN) POTENTIATES CYCLOSPORINE IN PREVENTION OF ACUTE LUNG REJECTION
J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 714 - 718.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. C. Wain, C. D. Wright, D. P. Ryan, S. L. Zorb, D. J. Mathisen, and L. C. Ginns
Induction immunosuppression for lung transplantation with OKT3
Ann. Thorac. Surg., January 1, 1999; 67(1): 187 - 193.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
G. K. Thyagarajan, A. Cobanoglu, and W. Johnston
FK506-Induced Fulminant Leukoencephalopathy After Single-Lung Transplantation
Ann. Thorac. Surg., November 1, 1997; 64(5): 1461 - 1464.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
R. I. Whyte, S. J. Rossi, M. S. Mulligan, R. Florn, L. Baker, S. Gupta, F. J. Martinez, and J. P. Lynch III
Mycophenolate Mofetil for Obliterative Bronchiolitis Syndrome After Lung Transplantation
Ann. Thorac. Surg., October 1, 1997; 64(4): 945 - 948.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. J. Keenan, A. Iacono, J. H. Dauber, A. Zeevi, S. A. Yousem, N. P. Ohori, G. J. Burckart, A. Kawai, G. C. Smaldone, and B. P. Griffith
TREATMENT OF REFRACTORY ACUTE ALLOGRAFT REJECTION WITH AEROSOLIZED CYCLOSPORINE IN LUNG TRANSPLANT RECIPIENTS
J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 335 - 341.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
P. Mattsson, A. Zeevi, J. Cai, S. A. Yousem, R. Hoffman, M. Nalesnik, G. J. Burckart, D. Geller, and B. P. Griffith
Effect of Aminoguanidine and Cyclosporine on Lung Allograft Rejection
Ann. Thorac. Surg., July 1, 1996; 62(1): 207 - 212.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
R. M. Bolman III
Advantage-FK 506: Reduced Chronic Rejection for Lung Transplant Recipients
Ann. Thorac. Surg., September 1, 1995; 60(3): 495 - 496.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.